SCHEMBL4637005

SCHEMBL4637005

CC(C)(C)OC(=O)Nc1c(O)cccc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 2/20 0.49
PLK1 P53350 1/20 0.44
ATR Q13535 1/20 0.43
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
HMGB1 P09429 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA7 P43166 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CA9 Q16790 1/20 0.42
NAPRT Q6XQN6 1/20 0.42
CA14 Q9ULX7 1/20 0.42
G6PD P11413 1/20 0.41
CASP7 P55210 1/20 0.41
CASP6 P55212 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8651106 0.91 ATR (0.47) ATRKDM4EALDH1A1CA12CA1
SCHEMBL26512493 0.87 ATR (0.46) ATRCA12CA1CA2CA7
SCHEMBL5242666 0.87 ATR (0.58) PTPN11ATRKDM4EALDH1A1CA12
SCHEMBL12884719 0.85 POLB (0.53) ATRKDM4EALDH1A1HPGDNAPRT
SCHEMBL31307595 0.84 HNF4A (0.46) ATRKDM4ESMN1; SMN2RXFP1MEN1
SCHEMBL14877165 0.84 MMP2 (0.44) ATRKDM4EALDH1A1G6PDCASP7
SCHEMBL646251 0.84 LCK (0.50) ATRALDH1A1HPGDRXFP1MEN1
SCHEMBL1346055 0.84 ALB (0.44) ATRKDM4EALDH1A1RXFP1MEN1
SCHEMBL28297521 0.84 KMT2A (0.50) ATRRXFP1MEN1NPC1RAB9A
SCHEMBL2997409 0.81 LCK (0.52) ATRCA12CA1CA9LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1883645-A4 DERIVATIVES OF 4-OR 5-AMINOSALICYLIC ACID ANTIBE THERAPEUTICS INC (US) 2008-06-25 EP disclosed
EP-1883645-A1 DERIVATIVES OF 4-OR 5-AMINOSALICYLIC ACID Antibe Therapeutics Inc. (US) 2008-02-06 EP disclosed
WO-2006125295-A1 DERIVATIVES OF 4-OR 5-AMINOSALICYLIC ACID ANTIBE THERAPEUTICS INC. (CA) 2006-11-30 WO disclosed